Avecho Biotechnology ROCE 2024

Avecho Biotechnology Aktienanalyse

What does Avecho Biotechnology do?

Avecho Biotechnology Ltd is a company specializing in the research of technologies to make active ingredients in the cosmetics industry more effective. The company was founded in 2008 by Dr. Timo Roiko-Jokela and is headquartered in Oxfordshire, England. Avecho's business model is based on the innovation of active ingredient technologies. The company has developed a unique technology called Invisicare® that is able to release active ingredients over a longer period of time, resulting in higher effectiveness in application. This technology also allows for better transportation of the active ingredients through the skin while protecting the skin barrier. Avecho Biotechnology has various divisions that focus on different areas of the cosmetics industry, including skincare, sunscreens, haircare, oral care, and body care. Within these divisions, the company offers various products based on the Invisicare® technology, including creamy lotions, serums, sunscreens, and shampoos. One example product from Avecho is the SolarCare range of sun care products, which are able to protect the skin from the harmful effects of UV rays while moisturizing the skin. Another example is the SkinPep range, which is specifically tailored to the needs of the skin and has high effectiveness due to its unique formula and technology. Avecho's innovations and products are utilized by a variety of cosmetics companies and brands. The company works closely with its customers to develop customized products that are tailored to their individual requirements. In recent times, Avecho has expanded its research and development efforts in the field of dermatology. The company is working to find innovative solutions for skin conditions such as psoriasis, eczema, and acne. The Invisicare® technology from Avecho is a key element in improving the effectiveness of active ingredients and protecting the skin barrier. Overall, Avecho Biotechnology is an innovative company specializing in the development of technologies and products in the cosmetics and dermatology industry. With its unique Invisicare® technology, the company provides customized solutions for the individual needs of its customers. Avecho Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Avecho Biotechnology's Return on Capital Employed (ROCE)

Avecho Biotechnology's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Avecho Biotechnology's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Avecho Biotechnology's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Avecho Biotechnology’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Avecho Biotechnology stock

What is the ROCE (Return on Capital Employed) of Avecho Biotechnology this year?

The ROCE of Avecho Biotechnology is -0.55 undefined this year.

How has the ROCE (Return on Capital Employed) of Avecho Biotechnology developed compared to the previous year?

The ROCE of Avecho Biotechnology has increased by -45.27% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Avecho Biotechnology?

A high Return on Capital Employed (ROCE) indicates that Avecho Biotechnology has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Avecho Biotechnology?

A low ROCE (Return on Capital Employed) can indicate that Avecho Biotechnology has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Avecho Biotechnology impact the company?

An increase in the ROCE of Avecho Biotechnology can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Avecho Biotechnology affect the company?

A decrease in ROCE of Avecho Biotechnology can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Avecho Biotechnology?

Some factors that can affect Avecho Biotechnology's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Avecho Biotechnology so important for investors?

The ROCE of Avecho Biotechnology is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Avecho Biotechnology take to improve the ROCE?

To improve the ROCE, Avecho Biotechnology can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Avecho Biotechnology pay?

Over the past 12 months, Avecho Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avecho Biotechnology is expected to pay a dividend of 0 AUD.

What is the dividend yield of Avecho Biotechnology?

The current dividend yield of Avecho Biotechnology is .

When does Avecho Biotechnology pay dividends?

Avecho Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avecho Biotechnology?

Avecho Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Avecho Biotechnology?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avecho Biotechnology located?

Avecho Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avecho Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avecho Biotechnology from 6/6/1997 amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on 5/14/1997.

When did Avecho Biotechnology pay the last dividend?

The last dividend was paid out on 6/6/1997.

What was the dividend of Avecho Biotechnology in the year 2023?

In the year 2023, Avecho Biotechnology distributed 0 AUD as dividends.

In which currency does Avecho Biotechnology pay out the dividend?

The dividends of Avecho Biotechnology are distributed in AUD.